By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to ...

When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set ...

A major shift in federal drug policy is raising questions across the country—including in Oklahoma—after President Trump ...

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...

The dispute centers on whether short-term rentals should be taxed as businesses. Lara says every other county assessor in New ...

The Trump admin reclassified FDA-approved products with marijuana and products that have a state medical license.

The DEA announced the new requirements for medical marijuana dispensaries seeking federal compliance, including application ...

The Trump administration's reclassification of medical marijuana as a Schedule III controlled substance is poised to ...

A major shift in federal marijuana policy could soon change how cannabis and some CBD businesses operate across Colorado.

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less ...

Legal rules around medical marijuana have been loosened, following an April 23 order from the Acting U.S. Attorney General ...

What reclassification means for license holders, dispensaries ...